Use of Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Drug Development for Ischemic Stroke
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
2
Page:
131-141
Author(s):
Turgut Tatlisumak and Fuhai Li
Microglial Proteases: Strategic Targets for Neuroprotective Agents
Journal:
Current Neuropharmacology
Volume:
1
Page:
99-108
Author(s):
Hiroshi Nakanishi
Genetic Polymorphism and Tumor Immunotherapy
Journal:
Current Pharmacogenomics
Volume:
1
Page:
37-57
Author(s):
Rongcun Yang and Richard B.S. Roden
Preface
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
3
Page:
ii-iI
Author(s):
Mark R. Emmerling and Alex E. Roher
Modulation of Alzheimers Amyloidosis by Statins: Mechanisms of Action
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
3
Page:
1-7
Author(s):
Suzana Petanceska, Miguel Pappolla and Lorenzo M. Refolo
A Rationale for Curcuminoids for the Prevention or Treatment of Alzheimers Disease
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
3
Page:
15-25
Author(s):
G. M. Cole, F. Yang, G. P. Lim, J. L. Cummings, D. L. Masterman and S. A. Frautschy
The Association of Microglial Activation and Amyloid Reduction in APP+PS1 Transgenic Mice
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
3
Page:
27-32
Author(s):
Dave Morgan, Paul Jantzen, Donna Wilcock, Giovanni DiCarlo, Ken Ugen and Marcia Gordon
Oxidative Mediated Neurodegeneration in Alzheimers Disease: Melatonin and Related Indoles as Neuroprotective Agents
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
3
Page:
33-46
Author(s):
M. A. Pappolla, R. J. Reiter, T. K. Bryant-Thomas and B. Poeggeler
BACE1 Deficient Mice: Their Role in Drug Target Validation and Implications for Alzheimers Disease Therapies
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
3
Page:
47-55
Author(s):
Robert Vassar
Immunotoxin Lesion of the Cholinergic Nucleus Basalis Causes Aβ Deposition: Towards a Physiologic Animal Model of Alzheimers Disease
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
3
Page:
57-75
Author(s):
T. G. Beach, D. G. Walker, L. I. Sue, S. Scott, K. J. Layne, A. J. Newell, P. E. Potter, R. A. Durham, M. R. Emmerling and S. D. Webster